Pharmacy Times Annual Survey Recognizes FOCUSfactor as the Leading Pharmacist-Recommended Brand in the Memory-Support Category ...

Strategic investment set to accelerate Nexthink's innovation and unlock a new era of AI-powered, agentic Digital Employee Experience (DEX) ...

NT-0796 is an oral, brain-penetrant NLRP3 inhibitor that selectively regulates chronic inflammation, a key driver of cardiometabolic diseasesExpects to complete the ongoing NT-0796 monotherapy trial ...

Jefferson Capital, Inc. (NASDAQ: JCAP) ('Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts, announced today that a wholly owned ...

Scott Walters, Chief Executive Officer of the Company, commented, "The historical results at the Lotto Property provide a compelling indication of the strong discovery potential we see across the ...

BMF-650 is an investigational, next-generation oral small-molecule GLP-1 RA being developed by Biomea Fusion for the treatment of obesity. Related to the broader orforglipron chemotype, BMF-650 is ...

A once-ignored corner of the American economy is roaring back to life. After years of dependence on Chinese supply chains, the Pentagon has launched a sweeping plan to rebuild domestic production of ...

BexBack, a global cryptocurrency derivatives platform, today announced the launch of its enhanced crypto futures trading service, offering High-Leverage Trading and simplified onboarding. With Bitcoin ...

Southeast Asia's Asean bloc will not send observers to Myanmar's elections in December, diplomatic sources said Monday — a setback to the junta's push for international legitimacy.

Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ('Osisko Development' or the 'Company') reports that, on October 17, 2025, Osisko Development acquired, indirectly through its wholly-owned subsidiary, ...